These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22787852)

  • 1. [Genetic diagnosis and imaging genetics of Alzheimer's disease].
    Miyashita A; Kuwano R
    Nihon Rinsho; 2011 Oct; 69 Suppl 8():565-9. PubMed ID: 22787852
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
    Mosconi L; De Santi S; Rusinek H; Convit A; de Leon MJ
    Expert Rev Neurother; 2004 Sep; 4(5):831-49. PubMed ID: 15853510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in the diagnosis of Alzheimer's disease].
    Jarema M
    Wiad Lek; 1990 Jun; 43(11):530-5. PubMed ID: 2219920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging and in vivo quantitation of beta-amyloid: an exemplary biomarker for Alzheimer's disease?
    Nichols L; Pike VW; Cai L; Innis RB
    Biol Psychiatry; 2006 May; 59(10):940-7. PubMed ID: 16487944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's biomarker initiative hits its stride.
    Miller G
    Science; 2009 Oct; 326(5951):386-9. PubMed ID: 19833956
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and pathological examples of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia.
    Salloway S
    Med Health R I; 2012 Jul; 95(7):207-9. PubMed ID: 22928231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroimaging Alzheimer's disease: early diagnosis, monitoring, and mechanism understanding].
    Chételat G
    Med Sci (Paris); 2011 Feb; 27(2):193-8. PubMed ID: 21382329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Reversible" Alzheimer's disease?
    Peter F; Susanne J; Margareta H; Silvia W; Wolfgang K; Thomas L; Heinz TK
    J Am Geriatr Soc; 2011 Jun; 59(6):1137-8. PubMed ID: 21668917
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.
    Masters CL; Cappai R; Barnham KJ; Villemagne VL
    J Neurochem; 2006 Jun; 97(6):1700-25. PubMed ID: 16805778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuro-ophthalmic findings in the visual variant of Alzheimer's disease.
    Lee AG; Martin CO
    Ophthalmology; 2004 Feb; 111(2):376-80; discussion 380-1. PubMed ID: 15019393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dementia with features of Alzheimer's disease and HIV-associated dementia in an elderly man with AIDS.
    Brousseau KM; Filley CM; Kaye K; Kiser JJ; Adler LE; Connick E
    AIDS; 2009 May; 23(8):1029-31. PubMed ID: 19414994
    [No Abstract]   [Full Text] [Related]  

  • 12. New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population.
    Bouwman FH; Verwey NA; Klein M; Kok A; Blankenstein MA; Sluimer JD; Barkhof F; van der Flier WM; Scheltens P
    Dement Geriatr Cogn Disord; 2010; 30(1):1-7. PubMed ID: 20606438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seizures can precede cognitive symptoms in late-onset Alzheimer's disease.
    Picco A; Archetti S; Ferrara M; Arnaldi D; Piccini A; Serrati C; di Lorenzo D; Morbelli S; Nobili F
    J Alzheimers Dis; 2011; 27(4):737-42. PubMed ID: 21876255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological markers in the diagnosis of dementia and Alzheimer's disease].
    Meiner Z; Rosenmann H
    Harefuah; 2012 May; 151(5):289-93, 318. PubMed ID: 22844733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET imaging, EEG and sleep phenotypes as translational biomarkers for research in Alzheimer's disease.
    Platt B; Welch A; Riedel G
    Biochem Soc Trans; 2011 Aug; 39(4):874-80. PubMed ID: 21787316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of temporal and parietal cortex in progressive nonfluent aphasia and Alzheimer's disease using chemical shift imaging, voxel-based morphometry and positron emission tomography.
    Zahn R; Buechert M; Overmans J; Talazko J; Specht K; Ko CW; Thiel T; Kaufmann R; Dykierek P; Juengling F; Hüll M
    Psychiatry Res; 2005 Nov; 140(2):115-31. PubMed ID: 16253483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic imaging of Alzheimer's disease].
    Sasaki M
    Seishin Shinkeigaku Zasshi; 2002; 104(6):455-7. PubMed ID: 12373799
    [No Abstract]   [Full Text] [Related]  

  • 18. Can dynamic susceptibility contrast magnetic resonance imaging replace single-photon emission computed tomography in the diagnosis of patients with Alzheimer's disease? A pilot study.
    Cavallin L; Danielsson R; Oksengard AR; Wahlund LO; Julin P; Frank A; Engman EL; Svensson L; Kristoffersen Wiberg M
    Acta Radiol; 2006 Nov; 47(9):977-85. PubMed ID: 17077051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrophy of the hippocampus, parietal cortex, and insula in Alzheimer's disease: a volumetric magnetic resonance imaging study.
    Foundas AL; Leonard CM; Mahoney SM; Agee OF; Heilman KM
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Apr; 10(2):81-9. PubMed ID: 9150507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease.
    Reiman EM; Uecker A; Caselli RJ; Lewis S; Bandy D; de Leon MJ; De Santi S; Convit A; Osborne D; Weaver A; Thibodeau SN
    Ann Neurol; 1998 Aug; 44(2):288-91. PubMed ID: 9708558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.